Clinical Trial Update: A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates recruitment is ongoing to test Vicadrostat in combination with Empagliflozin for Chronic Kidney Disease, sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Empagliflozin (empagliflozin)
• Vicadrostat

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Chronic Kidney Disease | Phase 2 | Status: RECRUITING